Scientists find immune response role for tumour suppressor
This article was originally published in Scrip
Researchers have found a new role in cell immunity for the tumour suppressor protein Tsc1 that could point the way to new therapies. Writing in Nature Immunology, scientists from St Jude Children's Research Hospital say that Tsc1 plays an important part in T cell quiescence, a process crucial to proper immune cell function.
You may also be interested in...
The Russian ministry of health has raised eyebrows by approving a vaccine against SARS-CoV-2 just weeks after its first clinical trials in 76 volunteers. Phase III confirmatory studies await for the adenovirus-based product but a mass vaccination plan is slated to begin in October.
A first look at the clinical data for Novavax’s COVID-19 vaccine suggests it can produce strong antibody responses while being well tolerated.
A couple of unexpected events for pimavanserin mean that Acadia will drop its development for major depressive disorder and have to wait a little longer to hear if it can launch the product for dementia-related psychosis, a large potential indication.